Nymox Pharmaceutical Common Stock

Nymox Pharmaceutical (NYMX) currently reports a common stock of $180M as of December 2024. That compares with $170M in the prior-year period — up 2.2% year over year. Use the charts on this page to explore Nymox Pharmaceutical's common stock history and peer comparisons.

Nymox Pharmaceutical's common stock increased from $170M to $180M — a 2.2% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nymox Pharmaceutical reported $180M in common stock as of December 2024. That compares with $170M in the prior-year period — up 2.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nymox Pharmaceutical, and consider following NYMX for alerts when major investors trade the stock.

Nymox Pharmaceutical is classified in the Healthcare sector. On common stock, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NYMX with unrelated industries.